NCT03951831 2025-04-25
REGN2810 Followed by Chemoimmunotherapy for Newly Metastatic Hormone-sensitive Prostate Cancer
Columbia University
Phase 2 Active not recruiting
Columbia University
Memorial Sloan Kettering Cancer Center
Regina Elena Cancer Institute
Dendreon
Memorial Sloan Kettering Cancer Center
University of Washington